Simultaneous inhibition of JAK and HDAC could enhance the efficacy of HDAC inhibitors in treating cancers and fungal infections, offering a solution to the resistance issue against HDAC inhibitors in some tumors. This evidence concerns the gene HDAC9 and fungal infectious disease.